Kairos Pharma KAPA
NYSE KAPA
$0.60 +0.02 (+2.71%)
As of: Oct 21, 2026 · 3:59 PM EDT

Kairos Pharma (KAPA) Non-Current Assets (2023 - 2025)

Updated

Kairos Pharma (KAPA) recorded Non-Current Assets of $1.15 million in Q4 2025, down 27.9% from $1.6 million a year earlier.

Analysis

Kairos Pharma (KAPA) Non-Current Assets (2023 - 2025) Analysis & Trends

Starting with Q4 2023, Kairos Pharma's Non-Current Assets history includes 6 quarters.

  • Across earlier years, Non-Current Assets came in at $1.6 million in FY2024 (+85.1%) and $864,000 in FY2023.
  • The Q4 2025 figure is the lowest quarterly Non-Current Assets since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 77.61 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 141.29 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 101.45 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 125.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 94.68 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 87.87 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 60.68 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 35.42 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 159.77 Bn
10 Kairos Pharma 10.86 Mn -1.55 Mn - 1.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.15 Mn
Jun 30, 2025 1.83 Mn
Mar 31, 2025 1.89 Mn
Dec 31, 2024 1.60 Mn
Sep 30, 2024 262,000.00
Dec 31, 2023 864,000.00
API Access

Kairos Pharma Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=KAPA&period=max&api_key=YOUR_API_KEY